Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

p62: Metabolism and the tumour microenvironment

Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA
p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )
29 Apr 2016

Cancer cells plasticity and drug resistance

Dr Rafaella Sordella - Cold Harbor Spring Laboratory, New York, USA
Cancer cells plasticity and drug resistance ( Dr Rafaella Sordella - Cold Harbor Spring Laboratory, New York, USA )
29 Apr 2016

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions

Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA
Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions ( Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
29 Apr 2016

Drugging “undruggable” transcription factor drivers in cancer

Dr John Bushweller - Unviersity of Virgina, Virginia, USA
Drugging “undruggable” transcription factor drivers in cancer ( Dr John Bushweller - Unviersity of Virgina, Virginia, USA )
28 Apr 2016

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
28 Apr 2016

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )
28 Apr 2016

Elucidation and pharmacological targeting of tumour checkpoint dependencies

Dr Andrea Califano - Colombia University Medical Centre, New York, USA
Elucidation and pharmacological targeting of tumour checkpoint dependencies ( Dr Andrea Califano - Colombia University Medical Centre, New York, USA )
28 Apr 2016

Identifying myeloid-driven biologies

Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA
Identifying myeloid-driven biologies ( Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA )
28 Apr 2016

Metastasis intiation mediated by thrombospondin 2

Dr Ilaria Malanchi - Crick Institute, London, UK
Metastasis intiation mediated by thrombospondin 2 ( Dr Ilaria Malanchi - Crick Institute, London, UK )
27 Apr 2016

New technology can potentially overcome CAR T-cell limitations

Dr Philip Low - Purdue University, West Lafayette, USA
New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )
27 Apr 2016

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016

Germ line predisposition to leukaemia

Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA
Germ line predisposition to leukaemia ( Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA )
27 Apr 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation